DUKE UNIVERSITY MEDICAL CENTER

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SIDLEY AUSTIN LLP	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	3
SENATE	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	4
Budget/Appropriations	Budget/Appropriations	4
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	4

Bills Explicitly Cited (12)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · third_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

Show 8 more cited filings

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · second_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

H.R. 5160119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

2026 · first_quarter · Firm: SIDLEY AUSTIN LLP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: —

Matched citations: H.R. 5160

Source: Senate LDA

DUKE UNIVERSITY MEDICAL CENTER — Lobbying Disclosure | Poliscope